Target ALS

A 501(c)(3) medical research foundation founded in 2013 that is committed to finding effective treatments for Amyotrophic Lateral Sclerosis (ALS). The organization works to accelerate ALS drug discovery and development by funding collaborative research and fostering partnerships between academia, the pharmaceutical/biotech industry, government, and non-profits. It provides researchers with funding and access to critical tools and resources, such as biospecimens and genomic datasets, with no intellectual property restrictions to remove barriers to innovation.